Affimed Gmbh competitive analysis

Explore patent oppositions filed by Affimed Gmbh against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition Date
Means And Methods For Treating DlbclAMGEN RESEARCH MUNICHDec 21, 2018
Means And Methods For Treating DlbclAMGEN RESEARCH MUNICHAug 25, 2016
Dosage Regimen For Administering A Cd19Xcd3 Bispecific AntibodyAMGEN RESEARCH MUNICHMay 12, 2016

Explore Affimed Gmbh's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleTotal Oppositions
Apr 5, 2023Trifunctional Antigen-Binding Molecule1

Latest PTAB cases involving Affimed Gmbh

Discover the latest PTAB cases involving Affimed Gmbh, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Affimed Gmbh with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 3, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AFFIMED GMBH31 - -
AMGEN RESEARCH MUNICH - 39 - -
STRAWMAN470 - - -